Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR)
CUSIP: 517125100
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 103,654,385
- Total 13F shares
- 14,519,322
- Share change
- -24,683
- Total reported value
- $167,488,004
- Price per share
- $11.53
- Number of holders
- 50
- Value change
- +$199,976
- Number of buys
- 28
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 517125100?
CUSIP 517125100 identifies LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 517125100:
Top shareholders of LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
5.6%
|
5,830,249
|
$57,253,000 | — | 30 Jun 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.5%
|
1,515,151
|
$14,879,000 | — | 30 Jun 2021 | |
| CHI Advisors LLC |
13F
|
Company |
1.5%
|
1,515,148
|
$14,879,000 | — | 30 Jun 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
0.77%
|
799,662
|
$7,853,000 | — | 30 Jun 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.7%
|
727,800
|
$7,147,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.64%
|
664,370
|
$6,525,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.58%
|
600,960
|
$5,886,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
308,143
|
$3,026,000 | — | 30 Jun 2021 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
0.28%
|
292,184
|
$2,869,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
257,868
|
$2,532,000 | — | 30 Jun 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.25%
|
256,620
|
$2,520,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.24%
|
251,900
|
$2,473,000 | — | 30 Jun 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.24%
|
244,675
|
$2,403,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
210,500
|
$2,067,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
195,774
|
$1,923,000 | — | 30 Jun 2021 | |
| Fi3 FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.12%
|
121,818
|
$1,218,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
112,454
|
$1,104,000 | — | 30 Jun 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.1%
|
100,000
|
$982,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.1%
|
99,160
|
$974,000 | — | 30 Jun 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.07%
|
76,987
|
$756,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.07%
|
76,680
|
$753,000 | — | 30 Jun 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.05%
|
52,968
|
$520,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
39,033
|
$383,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
34,586
|
$339,000 | — | 30 Jun 2021 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.03%
|
28,064
|
$276,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
24,494
|
$240,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
24,358
|
$239,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
18,973
|
$187,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
14,314
|
$141,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
13,718
|
$135,000 | — | 30 Jun 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
10,163
|
$100,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,634
|
$65,000 | — | 30 Jun 2021 | |
| Solstein Capital, LLC |
13F
|
Company |
0%
|
4,477
|
$44,000 | — | 30 Jun 2021 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
4,000
|
$39,000 | — | 30 Jun 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
3,250
|
$32,000 | — | 30 Jun 2021 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
2,635
|
$26,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,345
|
$13,000 | — | 30 Jun 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
1,175
|
$12,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
751
|
$7,000 | — | 30 Jun 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
457
|
$4,000 | — | 30 Jun 2021 | |
| Penserra Capital Management LLC |
13F
|
Company |
0%
|
350
|
$3,000 | — | 30 Jun 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
157
|
$1,000 | — | 30 Jun 2021 | |
| Disciplined Investments, LLC |
13F
|
Company |
0%
|
116
|
$1,000 | — | 30 Jun 2021 | |
| Daniel Thomas O |
3/4/5
|
Director |
—
class O/S missing
|
8,300
|
— | — | 12 May 2021 |
Institutional Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR) as of Q3 2021
As of 30 Sep 2021,
Larimar Therapeutics, Inc. - Common Stock, par value $0.01 per share (LRMR) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,519,322 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), RA CAPITAL MANAGEMENT, L.P., CHI Advisors LLC, Opaleye Management Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Vivo Capital, LLC, CITADEL ADVISORS LLC, Atlas Venture Advisors, Inc., and 683 Capital Management, LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
42
Q3 2021 holders
50
Holder diff
8
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.